Application of Section 409A of the Internal Revenue Code. This Agreement, including the right to receive Company Stock upon satisfaction of the Vesting Schedule, is intended to be exempt from the requirements of section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) pursuant to the short-term deferral exemption thereunder, and this Agreement, including the right to receive Company Stock upon the satisfaction of the Vesting Schedule, shall be interpreted on a basis consistent with such intent.
Appears in 2 contracts
Samples: Deferred Stock Unit Grant Agreement (Auxilium Pharmaceuticals Inc), Restricted Stock Unit Grant Agreement (Auxilium Pharmaceuticals Inc)
Application of Section 409A of the Internal Revenue Code. This Agreement, including the right to receive Company Stock upon achievement of the Performance Goals and satisfaction of the Vesting Schedule, is intended to be exempt from the requirements of section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) pursuant to the short-term deferral exemption thereunder, and this Agreement, including the right to receive Company Stock upon the achievement of the Performance Goals and satisfaction of the Vesting Schedule, shall be interpreted on a basis consistent with such intent.
Appears in 1 contract
Samples: Restricted Stock Unit Grant Agreement (Auxilium Pharmaceuticals Inc)
Application of Section 409A of the Internal Revenue Code. This Agreement, including the right to receive Company Stock upon achievement of the Performance Goal and satisfaction of the Vesting Schedule, is intended to be exempt from the requirements of section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) pursuant to the short-term deferral exemption thereunder, and this Agreement, including the right to receive Company Stock upon the achievement of the Performance Goal and satisfaction of the Vesting Schedule, shall be interpreted on a basis consistent with such intent.
Appears in 1 contract
Samples: Restricted Stock Unit Grant Agreement (Auxilium Pharmaceuticals Inc)